Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
22
NMPA:22
Drug Approvals
Human Erythropoietin Injection
- Product Name
- 济脉欣
- Approval Number
- 国药准字S20237018
- Approval Date
- Dec 28, 2023
NMPA
Human Granulocyte Colony-stimulating Factor Injection
- Product Name
- 吉赛欣
- Approval Number
- 国药准字S20227008
- Approval Date
- May 9, 2022
NMPA
Recombinant Hepatitis B Vaccine(CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S20103001
- Approval Date
- Feb 5, 2021
NMPA
Recombinant Hepatitis B Vaccine(CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S20113004
- Approval Date
- Feb 5, 2021
NMPA
Human Erythropoietin Injection
- Product Name
- 济脉欣
- Approval Number
- 国药准字S20053076
- Approval Date
- Apr 30, 2020
NMPA
Human Erythropoietin Injection
- Product Name
- 济脉欣
- Approval Number
- 国药准字S20133012
- Approval Date
- Apr 30, 2020
NMPA
Recombinant Hepatitis B Vaccine (CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S20053092
- Approval Date
- Apr 30, 2020
NMPA
Human Erythropoietin Injection
- Product Name
- 济脉欣
- Approval Number
- 国药准字S20000027
- Approval Date
- Apr 30, 2020
NMPA
Human Erythropoietin Injection
- Product Name
- 济脉欣
- Approval Number
- 国药准字S20053077
- Approval Date
- Apr 30, 2020
NMPA
Recombinant Hepatitis B Vaccine (CHO Cell)
- Product Name
- 重组乙型肝炎疫苗(CHO细胞)
- Approval Number
- 国药准字S20010036
- Approval Date
- Apr 30, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found